Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR

globenewswire.com
TMO Thermo Fisher Scientific is mentioned as a participant in the immunogenomics market, which is projected to grow. The article does not provide specific sentiment towards the company's performance or prospects. ILMN Illumina, Inc. is listed as a participant in the immunogenomics market. The article discusses market growth driven by technologies like Next-Generation Sequencing (NGS), which is a key area for Illumina, but offers no specific sentiment. QGEN QIAGEN N.V. is identified as a participant in the immunogenomics market. The article highlights the market's growth and the role of various technologies and applications, but provides no direct sentiment on QIAGEN. ROG Roche is mentioned as a participant in the immunogenomics market. The article forecasts market growth driven by advancements in personalized medicine and oncology, areas relevant to Roche, but without specific company sentiment. AGNC Agilent Technologies, Inc. is listed as a participant in the immunogenomics market. The article discusses market expansion and technological advancements, but does not offer specific sentiment towards Agilent. BIO Bio-Rad Laboratories, Inc. is named as a participant in the immunogenomics market. The article forecasts growth for the market due to factors like personalized medicine and genomic analysis, but provides no specific sentiment for Bio-Rad. PACB Pacific Biosciences of California, Inc. is mentioned as a participant in the immunogenomics market. The article highlights growth drivers such as NGS, a key technology for PacBio, but offers no direct sentiment on the company. ONT Oxford Nanopore Technologies plc is listed as a participant in the immunogenomics market. The article discusses market growth and technological advancements, but provides no specific sentiment towards Oxford Nanopore. CDNA CareDx, Inc. is identified as a participant in the immunogenomics market. The article forecasts market growth driven by personalized medicine and clinical applications, which are key areas for CareDx, but provides no specific sentiment.

Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR Dublin, Oct. 05, 2026 (GLOBE NEWSWIRE) -- "Immunogenomics Market Size, Share & Trends Analysis Report by Type, Technology, Application, End Use, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global immunogenomics market size was estimated at USD 6.32 billion in 2025 and is projected to reach USD 9.82 billion by 2033. The market is expected to expand at a CAGR of 5.97% from 2026 to 2033, supported by advancements in next-generation sequencing technologies, growing demand for personalized medicine and the rising prevalence of immune-related disorders.

Continued innovation in genomic analysis is strengthening the role of immunogenomics across clinical diagnostics, oncology, infectious disease research, vaccine development and autoimmune disorder studies. Pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories and academic research institutions are increasingly adopting advanced sequencing, PCR, microarray and analytical software solutions to support biomarker discovery, therapeutic development and precision healthcare strategies.

Global Immunogenomics Market Report Segmentation

The report provides revenue analysis, market estimates and forecasts for key sub-segments from 2021 to 2033. It evaluates the global immunogenomics market by product type, technology, application, end user and region, while examining the trends, opportunities and competitive factors influencing market development.

Product Type Outlook (Revenue, USD Million, 2021-2033)

Demand across these product categories is being shaped by expanding genomic research, increasing test volumes and the need for integrated data analysis platforms. Consumables support recurring laboratory workflows, while instruments and software remain essential to sequencing, sample processing and interpretation.

Technology Outlook (Revenue, USD Million, 2021-2033)

Application Outlook (Revenue, USD Million, 2021-2033)

Clinical and research applications are benefiting from greater access to genomic datasets and advanced molecular technologies. Oncology / Cancer Immunotherapy remains a major area of interest as organizations investigate immune response pathways, treatment selection and therapeutic outcomes. Infectious Diseases & Vaccine Research and autoimmune disorder studies are also contributing to broader market adoption.

End User Outlook (Revenue, USD Million, 2021-2033)

Regional Outlook (Revenue, USD Million, 2021-2033)

The regional assessment highlights variations in research investment, healthcare infrastructure, genomic testing capacity and technology adoption. It enables stakeholders to compare established and emerging immunogenomics markets, assess country-level revenue potential and identify areas that may support future expansion.

Key Benefits of the Immunogenomics Market Report

The report delivers market intelligence to support effective decision-making, investment planning, competitive positioning and long-term growth strategies. It combines market estimates and forecasts with trend analysis, product innovation insights and assessments of emerging opportunities, helping companies evaluate demand across technologies, applications, end users and geographic markets. These findings can assist industry participants in refining commercialization plans, prioritizing research initiatives and responding to changes in the global immunogenomics market.

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Market Definitions

1.2.1. Product type

1.2.2. Technology

1.2.3. Application

1.2.4. End Use

1.3. Information or Data Analysis

1.4. Data Visualization

1.5. Data Validation & Publishing

1.6. Information Procurement

1.6.1. Primary Research

1.7. Market Formulation & Validation

1.8. Market Model

1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/Ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.2.3. Market Opportunity Analysis

3.2.4. Market Challenge Analysis

3.3. Industry Analysis Tools

3.3.1. Porter's Five Forces Analysis

3.3.2. PESTEL Analysis

Chapter 4. Immunogenomics Market: Product Type Business Analysis

4.1. Product Type Segment Dashboard

4.2. Global Immunogenomics Market Product Type Movement Analysis

4.3. Global Immunogenomics Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)

4.4. Instruments

4.4.1. Global Instruments Market Estimates and Forecasts, 2021-2033 (USD Million)

4.5. Consumables

4.5.1. Global Consumables Market Estimates and Forecasts, 2021-2033 (USD Million)

4.6. Software

4.6.1. Global Software Market Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 5. Immunogenomics Market: Technology Business Analysis

5.1. Technology Segment Dashboard

5.2. Global Immunogenomics Market Technology Movement Analysis

5.3. Global Immunogenomics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)

5.4. Next-Generation Sequencing (NGS)

5.4.1. Global Next-Generation Sequencing (NGS) Market Estimates and Forecasts, 2021-2033 (USD Million)

5.5. Polymerase Chain Reaction (PCR)

5.5.1. Global Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2021-2033 (USD Million)

5.6. Microarray

5.6.1. Global Microarray Market Estimates and Forecasts, 2021-2033 (USD Million)

5.7. Other Technologies

5.7.1. Global Other Technologies Market Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 6. Immunogenomics Market: Application Business Analysis

6.1. Application Segment Dashboard

6.2. Global Immunogenomics Market Application Movement Analysis

6.3. Global Immunogenomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)

6.4. Clinical Applications

6.4.1. Global Clinical Applications Market Estimates and Forecasts, 2021-2033 (USD Million)

6.4.2. Oncology / Cancer Immunotherapy

6.4.3. Infectious Diseases & Vaccine Research

6.4.4. Autoimmune Disorders

6.4.5. Others

6.5. Research Applications

6.5.1. Global Research Applications Market Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 7. Immunogenomics Market: End User Business Analysis

7.1. End User Segment Dashboard

7.2. Global Immunogenomics Market End User Movement Analysis

7.3. Global Immunogenomics Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)

7.4. Hospitals & Diagnostic Laboratories

7.4.1. Global Hospitals & Diagnostic Laboratories Market Estimates and Forecasts, 2021-2033 (USD Million)

7.5. Academic & Research Institutes

7.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2021-2033 (USD Million)

7.6. Pharmaceutical & Biotechnology Companies

7.6.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021-2033 (USD Million)

7.7. Other End Users

7.7.1. Global Other End Users Market Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 8. Immunogenomics Market: Regional Estimates & Trend Analysis by Product Type, Technology, Application, & End User

8.1. Regional Dashboard

8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033

8.3. North America

8.3.1. North America Immunogenomics Market Estimates and Forecasts, 2021-2033 (USD Million)

8.3.2. U.S.

8.3.3. Canada

8.3.4. Mexico

8.4. Europe

8.4.1. Europe Immunogenomics Market Estimates and Forecasts, 2021-2033 (USD Million)

8.4.2. UK

8.4.3. Germany

8.4.4. France

8.4.5. Italy

8.4.6. Spain

8.4.7. Denmark

8.4.8. Sweden

8.4.9. Norway

8.5. Asia-Pacific

8.5.1. Asia-Pacific Immunogenomics Market Estimates and Forecasts, 2021-2033 (USD Million)

8.5.2. Japan

8.5.3. China

8.5.4. India

8.5.5. Australia

8.5.6. Thailand

8.5.7. South Korea

8.6. Latin America

8.6.1. Latin America Immunogenomics Market Estimates and Forecasts, 2021-2033 (USD Million)

8.6.2. Brazil

8.6.3. Argentina

8.7. MEA

8.7.1. MEA Immunogenomics Market Estimates and Forecasts, 2021-2033 (USD Million)

8.7.2. South Africa

8.7.3. Saudi Arabia

8.7.4. UAE

8.7.5. Kuwait

Chapter 9. Competitive Landscape

9.1. Participant Categorization

9.2. Strategy Mapping

9.3. Company Market Share/Position Analysis, 2025

9.4. Participant Overview

9.4.1. Thermo Fisher Scientific

9.4.2. Illumina, Inc.

9.4.3. QIAGEN N.V.

9.4.4. F. Hoffmann-La Roche Ltd

9.4.5. Agilent Technologies, Inc.

9.4.6. Bio-Rad Laboratories, Inc.

9.4.7. Pacific Biosciences of California, Inc.

9.4.8. Oxford Nanopore Technologies plc

9.4.9. Eurofins Scientific SE

9.4.10. CareDx, Inc.

List of Tables [124]

List of Figures [68]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/cejhfe

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.